Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

A pilot study of a novel tapered and flared fully covered self-expandable metal stent for unresectable malignant distal biliary obstruction: a multicenter study in Japan

  • Toji Murabayashi (Department of Gastroenterology, Ise Red Cross Hospital) ;
  • Makoto Kobayashi (Department of Gastroenterology, Yokkaichi Municipal Hospital) ;
  • Keisuke Iwata (Department of Gastroenterology, Gifu Municipal Hospital) ;
  • Yuhei Iwasa (Department of Gastroenterology, Gifu Municipal Hospital) ;
  • Yujiro Kawakami (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University School of Medicine) ;
  • Yoshiharu Masaki (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University School of Medicine) ;
  • Shinya Kawaguchi (Department of Gastroenterology, Shizuoka General Hospital) ;
  • Hayato Nakagawa (Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine)
  • Received : 2025.10.25
  • Accepted : 2025.12.30
  • Published : 2026.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background/Aims: This study evaluated the feasibility and clinical outcomes of a novel tapered and flared, fully covered, self-expandable metal stent (TF-FCSEMS) for unresectable malignant distal biliary obstruction (UMDBO). Methods: This multicenter retrospective study included 40 patients who underwent transpapillary placement of a TF-FCSEMS (10-mm cylindrical body with an 8-mm tapered distal end) for UMDBO between May 2023 and July 2024. The primary outcome was time to recurrent biliary obstruction (TRBO). Secondary outcomes included technical and clinical successes, adverse events (AEs), and overall survival. Results: Technical and clinical success rates were 100% and 98%, respectively. During a median follow-up period of 271 days, recurrent biliary obstruction (RBO) occurred in 10 (26%) of the 39 patients who achieved clinical success. The median TRBO was 539 days (95% confidence interval, 389-not reached), and the non-RBO rates at 3, 6, and 12 months were 94%, 71%, and 61%, respectively. Symptomatic stent migration occurred in 2 patients (5.1%), while asymptomatic migration was observed in 3 (7.7%). Post-endoscopic retrograde cholangiopancreatography pancreatitis occurred in four patients (10%). Non-occlusion cholangitis developed in five (13%) patients, mostly with tumor-related duodenal stenosis. All AEs were managed conservatively or endoscopically. Conclusions: TF-FCSEMS appears to be a feasible and acceptable treatment option for UMDBO. Further prospective studies are required to confirm these findings.

Keywords

References

  1. Nakai Y, Isayama H, Wang HP, et al. International consensus statements for endoscopic management of distal biliary stricture. J Gastroenterol Hepatol 2020;35:967–979. https://doi.org/10.1111/jgh.v35.6
  2. Yamashita Y, Tachikawa A, Shimokawa T, et al. Covered versus uncovered metal stent for endoscopic drainage of a malignant distal biliary obstruction: meta-analysis. Dig Endosc 2022;34:938–951. https://doi.org/10.1111/den.v34.5
  3. Tamura T, Yamai T, Uza N, et al. Adverse events of self-expandable metal stent placement for malignant distal biliary obstruction: a large multicenter study. Gastrointest Endosc 2024;99:61–72. https://doi.org/10.1016/j.gie.2023.08.004
  4. Vanella G, Coluccio C, Cucchetti A, et al. Fully covered versus partially covered self-expandable metal stents for palliation of distal malignant biliary obstruction: a systematic review and meta-analysis. Gastrointest Endosc 2024;99:314–322. https://doi.org/10.1016/j.gie.2023.10.023
  5. Kobayashi M, Kato H, Tominaga S, et al. Novel tapered-and-flared fully covered self-expandable metal stent for distal bile duct obstruction. Endoscopy 2024;56:E464–E465. https://doi.org/10.1055/a-2325-2559
  6. Isayama H, Hamada T, Fujisawa T, et al. TOKYO criteria 2024 for the assessment of clinical outcomes of endoscopic biliary drainage. Dig Endosc 2024;36:1195–1210. https://doi.org/10.1111/den.v36.11
  7. Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 2018;25:41–54. https://doi.org/10.1002/jhbp.2018.25.issue-1
  8. Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci 2018;25:17–30. https://doi.org/10.1002/jhbp.2018.25.issue-1
  9. Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010;71:446–454. https://doi.org/10.1016/j.gie.2009.10.027
  10. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013;48:452–458. https://doi.org/10.1038/bmt.2012.244
  11. Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017. Endoscopy 2018;50:910–930. https://doi.org/10.1055/a-0659-9864
  12. Takeda T, Sasaki T, Okamoto T, et al. Endoscopic double stenting for the management of combined malignant biliary and duodenal obstruction. J Clin Med 2021;10:3372. https://doi.org/10.3390/jcm10153372
  13. Doi S, Namura Y, Kikuyama T, et al. Novel anti-reflux biliary metal stent with a distal tapered end for distal malignant biliary obstruction: a feasibility study. Endosc Int Open 2023;11:E460–E465. https://doi.org/10.1055/a-2039-3853
  14. Kawashima H, Hashimoto S, Ohno E, et al. Comparison of 8- and 10-mm diameter fully covered self-expandable metal stents: a multicenter prospective study in patients with distal malignant biliary obstruction. Dig Endosc 2019;31:439-447. https://doi.org/10.1111/den.2019.31.issue-4